2 ms·

But you would need much more participants in all trials, to make up for all those new combos that you now have to consider. Also: I can imagine that most of th

But you would need much more participants in all trials, to make up for all those new combos that you now have to consider. Also: I can imagine that most of the patients would be eager to engage in all possible treatments. You might not even have a control group that did not participate in the study of the faulty drug X

mitthrowaway2 3y ago
Then all you get is data about the effectiveness of XY. Would it be any better if only X was tested, but it turned out that that one drug 'X' contained two separate active ingredients, each of which the pharmaceutical company thought would probably be an effective treatment?